3 THINGS TO LOOK FOR SHORT TERM...
Release of Histology and Cytokine Data
The CEO stated in the PR announcing interim results that "The Company expects to provide final results including histology and cytokine data in the next few weeks."
This data is vital to allow the medical world to fully assess the effectiveness of Endonovo's device. The cytokine data is especially relevant as these pro inflammatories cause a tremendous amount of damage to the heart of a person who has suffered myocardial infarction. Endonovo has already shown a greater ability to improve the heart's contractility, specifically in the areas of fractional shortening and ejection fraction, than the currently prescribed drugs for prevention of remodeling.
If Endonovo shows substantial inhibition of the proteins created from these cytokines it could prove to be a more effective treatment than current therapies. Yes I said more, but don't take my word for it, do your own research.
It has now been 3 weeks since the interim results this data could come any day now.
Announcement of FDA Application
The CEO has stated "Our goal remains simple - complete our pre-clinical trials, release positive data, and aggressively continue down the regulatory pathway."
Once we find out the regulator path that endonovo will choose we will have a realistic timeframe for approval and subsequent clinical trials. Anyone familiar with biotech stocks knows the effect this can have on both the market cap and price per share.
With endonovo showing up on the FDA SRO list in the last couple weeks, this announcement could come at any time.
Continuation Patent Application
With such strong results in strengthening the heart's overall functionality. It is very probible that the company will look to add to the current patent, expanding from the current target of treating post MI symptoms to also targeting other chronic conditions were the heart is weakened. The use of this device as a preventive therapy could hold an even greater market potential than treating MI.
This could be announced at any time.
